J
Joseph Aisner
Researcher at Rutgers University
Publications - 246
Citations - 10711
Joseph Aisner is an academic researcher from Rutgers University. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 53, co-authored 245 publications receiving 10103 citations. Previous affiliations of Joseph Aisner include University of Maryland Marlene and Stewart Greenebaum Cancer Center & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.
Anne Auperin,Rodrigo Arriagada,J.P. Pignon,Le Péchoux C,A. Gregor,Richard Stephens,P. E.G. Kristjansen,B. E. Johnson,Hiroshi Ueoka,Henry N. Wagner,Joseph Aisner +10 more
TL;DR: Prophylactic cranial irradiation improves both overall survival and disease-free survival among patients with small-cell lung cancer in complete remission and identifies a trend toward a decrease in the risk of brain metastasis with earlier administration of cranials irradiation after the initiation of induction chemotherapy.
Journal ArticleDOI
Treatment of Invasive Aspergillosis: Relation of Early Diagnosis and Treatment to Response
TL;DR: Aspergillusinfections in patients with cancer are difficult to diagnose, and such diagnoses are frequently made at necropsy as discussed by the authors, and earlier therapy has been proposed to provide better response.
Journal Article
Pharmacokinetics and Dosage Reduction of cis-Diammine(1,1-cyclobutanedicarboxylato)platinum in Patients with Impaired Renal Function
Merrill J. Egorin,D A Van Echo,S. J. Tipping,E A Olman,Margaret Y. Whitacre,B W Thompson,Joseph Aisner +6 more
TL;DR: Calculations for theoretical patients (both pretreated and nonpretreated) with CCr of 100 ml/min produce dosages very close to maximum tolerated dosages derived in actual Phase I trials, although the actual clinical utility of these predictive equations must await validation in prospective studies with larger numbers of patients.
Journal ArticleDOI
Invasive Aspergillosis in Acute Leukemia: Correlation with Nose Cultures and Antibiotic Use
TL;DR: The data from all patients with acute nonlymphocytic leukemia treated at the authors' center during a 3-year period may help identify patients at risk of aspergillosis and help determine antifungal therapy when invasive procedures are contraindicated.
Journal ArticleDOI
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
TL;DR: Because of its substantial response in this phase II trial, the MAID regimen is being compared with doxorubicin and DTIC alone in advanced sarcoma and to observation in the adjuvant treatment of high-grade sarcomas in randomized trials.